|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Direct cost of revenues | |||||
| Gross profit | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Sales and marketing | |||||
| Depreciation of property and equipment | |||||
| Depreciation of right-of-use assets | |||||
| Foreign exchange loss (gain) | |||||
| Acquisition-related compensation | |||||
| Amortization of intangible assets | |||||
| Restructuring | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Net interest income | |||||
| Loss before income taxes | |||||
| Income tax expense (recovery) | |||||
| Current | |||||
| Deferred | |||||
| Total income tax expense | |||||
| Net loss | |||||
| Other comprehensive income (loss) | |||||
| Foreign currency differences on translation of foreign operations | |||||
| Change in net unrealized gain (loss) on cash flow hedging instruments, net of tax | |||||
| Total other comprehensive income (loss) | |||||
| Total comprehensive loss | |||||
| Basic net loss per share (in USD per share) | |||||
| Diluted net loss per share (in USD per share) |
Loading...